TY - JOUR
T1 - Erratum
T2 - Severe thrombocytopenia in patients with advanced neuroendocrine tumor treated with peptide receptor radioligand therapy (Clinical Nuclear Medicine (2022) 47 (409-413) DOI: 10.1097/RLU.0000000000004130)
AU - Ahmad, Junid A.Naveed
AU - Schroeder, Brett A.
AU - Ruhoy, Steven M.
AU - Lin, Bruce S.
AU - Kennecke, Hagen F.
N1 - Publisher Copyright:
© 2022 Lippincott Williams and Wilkins. All rights reserved.
PY - 2022/8/1
Y1 - 2022/8/1
N2 - In the article beginning on page 409 of the May 2022 issue, the authors report an error in the name and order of the authors. The correct name and order of authors appear below: Junid A. Naveed Ahmad, MD, Brett A. Schroeder, MD, Steven M. Ruhoy, MD, Bruce S. Lin, MD, and Hagen F. Kennecke, MD, MHA, FRCPC.
AB - In the article beginning on page 409 of the May 2022 issue, the authors report an error in the name and order of the authors. The correct name and order of authors appear below: Junid A. Naveed Ahmad, MD, Brett A. Schroeder, MD, Steven M. Ruhoy, MD, Bruce S. Lin, MD, and Hagen F. Kennecke, MD, MHA, FRCPC.
UR - http://www.scopus.com/inward/record.url?scp=85133628213&partnerID=8YFLogxK
U2 - 10.1097/RLU.0000000000004324
DO - 10.1097/RLU.0000000000004324
M3 - Comment/debate
C2 - 35797632
AN - SCOPUS:85133628213
SN - 0363-9762
VL - 47
SP - 754
JO - Clinical Nuclear Medicine
JF - Clinical Nuclear Medicine
IS - 8
ER -